A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2002
12/19/2002	WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002	WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/19/2002	WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002	WO2002055096A8 Local use of essential oils for treating badly healed wounds
12/19/2002	WO2002042248A3 Naphthalene derivatives
12/19/2002	WO2002011767A3 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
12/19/2002	WO2001087301A9 Methods for treatment of inflammatory diseases
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	US20020194631 Method of treating psoriasis using anti-interleukin 12 antibody
12/19/2002	US20020193875 Agent promoting the formation of skin basement membrane, agents promoting the formation of artificial skin and process for producing artificial skin
12/19/2002	US20020193634 Disulfide derivatives useful for treating allergic diseases
12/19/2002	US20020193633 Mast cell stabilizers
12/19/2002	US20020193614 Treatment of cardiovascular disorders
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193446 Compounds and methods for the inhibition of the expression of VCAM-1
12/19/2002	US20020193431 Administration of an effective amount of 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4, Lipoxin-A4, 15-epi-lipoxin4 or 15-R/S-methyl-lipoxin4 or salts, esters, amides, carboxylic acids or prodrugs to treat angiogenesis
12/19/2002	US20020193421 Substituted bonzoic acid derivatives, useful for preventing and/or treating tumors, arthritis, and non-malignant skin disorders
12/19/2002	US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
12/19/2002	US20020193396 Sulfonamido ether substituted imidazoquinolines
12/19/2002	US20020193377 Quinazolines as MMP-13 inhibitors
12/19/2002	US20020193321 Shelf life
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192647 Diagnostic method
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192638 Evaluation of cells sensitvity to anticancer agents; obtain tissue, separate, culture tissue, inoculate cells, incubate with anticancer agent, monitor sensitivity to anticancer agents
12/19/2002	US20020192313 Use of legume products for the treatment of external aggressions
12/19/2002	US20020192312 Pharmaceutical compositions
12/19/2002	US20020192288 Methods and compositions for treating pain of the mucous membrane
12/19/2002	US20020192276 Use of G class immunoglobulins for the topical treatment of atopic dermatitis
12/19/2002	US20020192272 Metronidazole pledgets
12/19/2002	US20020192253 Peeling composition
12/19/2002	US20020192216 Therapeutic use
12/19/2002	US20020192178 Leguminous extract heavy-metal-scavenging anti-pollution agent
12/19/2002	US20020192167 Use of sunscreen combinations which comprise, as essential constituent, 2-(4-alkoxyanilinomethylene) malonic dialkyl esters as photosatble uv filters in cosmetic and pharmaceutical preparations
12/19/2002	US20020192162 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002	US20020192157 Treatment and diagnosis of macrophage mediated disease
12/19/2002	DE10128911A1 Ascorbic acid is used in angiogenetically-effective cosmetic and dermatological topical preparations eg for treatment of skin or hair
12/19/2002	CA2450240A1 Treatment and composition for wound healing
12/19/2002	CA2449732A1 Porous sponge-like cellulosic material for treatment of injuries
12/19/2002	CA2449544A1 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	CA2449247A1 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	CA2448764A1 N-arylphenylacetamide derivatives and pharmaceutical compositions containing the same
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/18/2002	EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002	EP1266651A2 UV absorbing and photostabilizing agents and compositions and external preparation for skin
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266013A2 Heparinase iii and uses thereof
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265905A1 Il-8 receptor antagonists
12/18/2002	EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
12/18/2002	EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002	EP1265878A1 A process for the preparation of epothiline analogs and intermediates
12/18/2002	EP1265870A1 New ccr5 modulators: benzimidazoles or benzotriazoles
12/18/2002	EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
12/18/2002	EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
12/18/2002	EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265848A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
12/18/2002	EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1265627A2 Methods and compositions for inhibiting angiogenesis
12/18/2002	EP1265616A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
12/18/2002	EP1265613A2 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1265603A2 Il-8 receptor antagonists
12/18/2002	EP1265595A2 Stabilized ascorbic acid solutions
12/18/2002	EP1265570A1 Soluble keratin peptide
12/18/2002	EP1265483A2 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces
12/18/2002	EP1121088B1 Use of nanoscale sterols and sterol esters
12/18/2002	EP1104420B1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors
12/18/2002	EP1086101B1 Beta-carboline compounds
12/18/2002	EP1053221B1 Lipid mixtures and their use
12/18/2002	EP0934300B1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/18/2002	EP0929288B1 Skin care composition containing an amide and retinol or retinyl ester
12/18/2002	EP0881902B1 Combinations of peroxide lipids and organosilicon compounds, cosmetic and dermatological compositions containing same, and uses thereof, in particular for treating alopecia
12/18/2002	EP0871473B1 Use of il-10 for wound healing with reduced scarring
12/18/2002	EP0859784B1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
12/18/2002	EP0788792B1 Matrix type patch preparation
12/18/2002	EP0760668B1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
12/18/2002	CN1385457A 凝胶组合物 Gel compositions
12/18/2002	CN1385213A Decolouring technology for compound Chinese herbal medicine
12/18/2002	CN1385208A Fujingwan pill for curing dermatosis
12/18/2002	CN1385199A Compound phellodendron bark ringworm-removing liniment
12/18/2002	CN1385197A Ointment for wound healing
12/18/2002	CN1385187A Medicinal composition, its preparation process and use in treating psoriasis
12/18/2002	CN1385177A Medicine for beautifying face
12/18/2002	CN1385168A External used functional medicine whose Chinese medicine prescription intensified by snake macro-micro element
12/18/2002	CN1385161A Ointment prescription for treating trauma
12/18/2002	CN1096270C No scar scald treating ointment

1 ... 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 ... 1065